BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 32497020)

  • 21. Circular RNA circ-ERBB2 Elevates the Warburg Effect and Facilitates Triple-Negative Breast Cancer Growth by the MicroRNA 136-5p/Pyruvate Dehydrogenase Kinase 4 Axis.
    Huang Y; Zheng S; Lin Y; Ke L
    Mol Cell Biol; 2021 Sep; 41(10):e0060920. PubMed ID: 34370552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis.
    Xu JZ; Shao CC; Wang XJ; Zhao X; Chen JQ; Ouyang YX; Feng J; Zhang F; Huang WH; Ying Q; Chen CF; Wei XL; Dong HY; Zhang GJ; Chen M
    Cell Death Dis; 2019 Feb; 10(3):175. PubMed ID: 30787278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel circRNA circ_0045881 inhibits cell proliferation and invasion by targeting mir-214-3p in triple-negative breast cancer.
    Ren J; Chen W; Zhou Y; Sun J; Jiang G
    BMC Cancer; 2024 Mar; 24(1):278. PubMed ID: 38429642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.
    Zhang J; Xu HD; Xing XJ; Liang ZT; Xia ZH; Zhao Y
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5315-5322. PubMed ID: 31298383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA dehydrodolichyl diphosphate synthase facilitated triple-negative breast cancer progression via miR-362-3p/DDX5 axis.
    Cui S; Zhang Y; Xing L; Li R; Piao Y; Liu H
    Environ Toxicol; 2022 Jun; 37(6):1483-1494. PubMed ID: 35343646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p.
    Wang GP; Mou ZL; Xu YY; Liu GX; Wang DM; Zhang HP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7445-7456. PubMed ID: 31539132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circ_0004676 exacerbates triple-negative breast cancer progression through regulation of the miR-377-3p/E2F6/PNO1 axis.
    Shao G; Fan X; Zhang P; Liu X; Huang L; Ji S
    Cell Biol Toxicol; 2023 Oct; 39(5):2183-2205. PubMed ID: 35870038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CircSNX25 mediated by SP1 promotes the carcinogenesis and development of triple-negative breast cancer.
    Gao H; Tuluhong D; Li X; Zhu Y; Xu C; Wang J; Li H; Wang S; Ding W
    Cell Signal; 2023 Sep; 109():110776. PubMed ID: 37331414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CircHERC1 promotes non-small cell lung cancer cell progression by sequestering FOXO1 in the cytoplasm and regulating the miR-142-3p-HMGB1 axis.
    Cui Y; Wu X; Jin J; Man W; Li J; Li X; Li Y; Yao H; Zhong R; Chen S; Wu J; Zhu T; Lin Y; Xu J; Wang Y
    Mol Cancer; 2023 Nov; 22(1):179. PubMed ID: 37932766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CircCD44 plays oncogenic roles in triple-negative breast cancer by modulating the miR-502-5p/KRAS and IGF2BP2/Myc axes.
    Li J; Gao X; Zhang Z; Lai Y; Lin X; Lin B; Ma M; Liang X; Li X; Lv W; Lin Y; Zhang N
    Mol Cancer; 2021 Oct; 20(1):138. PubMed ID: 34696797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
    Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK/PI3K/AKT activation in a ceRNA manner.
    Zhang C; Yu Z; Yang S; Liu Y; Song J; Mao J; Li M; Zhao Y
    Mol Cancer; 2024 Feb; 23(1):33. PubMed ID: 38355583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
    J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-483-3p suppresses the proliferation and progression of human triple negative breast cancer cells by targeting the HDAC8>oncogene.
    Menbari MN; Rahimi K; Ahmadi A; Mohammadi-Yeganeh S; Elyasi A; Darvishi N; Hosseini V; Abdi M
    J Cell Physiol; 2020 Mar; 235(3):2631-2642. PubMed ID: 31508813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CircRNA_0058063 functions as a ceRNA in bladder cancer progression via targeting miR-486-3p/FOXP4 axis.
    Liang H; Huang H; Li Y; Lu Y; Ye T
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32181485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer.
    Fan Y; Wang J; Jin W; Sun Y; Xu Y; Wang Y; Liang X; Su D
    Mol Cancer; 2021 Feb; 20(1):25. PubMed ID: 33530981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
    Chen LL; Zhang ZJ; Yi ZB; Li JJ
    Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.